We examined the expression of CD44 variant forms and their binding to hyalu
ronan (HA) in lung cancer cell lines. There was no relationship between the
level of expression of CD44 variants and HA binding in different lung canc
er cell lines. The expression of CD44v6 and CD44E in some cell lines was no
t always associated with HA binding. There was no relationship between the
tissue pathological type and CD44 expression or HA binding. Deglycosylation
by neuraminidase induced CD44-HA binding in human lung cancer cell lines.
Our findings suggest that the EIA binding ability of CD44, which is negativ
ely regulated by glycosylation, might be a more important factor in tumorig
enesis or metastasis than the expression of CD44 variant forms.